Cargando…

Percutaneous Vertebroplasty versus Conservative Treatment Using a Transdermal Fentanyl Patch for Osteoporotic Vertebral Compression Fractures

OBJECTIVE: Although surgical intervention, such as percutaneous vertebroplasty (PVP), is the standard treatment for osteoporotic vertebral compression fractures (OVCFs), its effectiveness and safety are unclear. Therefore, this study compared the safety and efficacy of conservative treatment with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Younggyu, Lee, Byungjou, Lee, Subum, Kim, Junghwan, Park, Jinhoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurosurgical Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732346/
https://www.ncbi.nlm.nih.gov/pubmed/31484234
http://dx.doi.org/10.3340/jkns.2019.0086
_version_ 1783449807461810176
author Oh, Younggyu
Lee, Byungjou
Lee, Subum
Kim, Junghwan
Park, Jinhoon
author_facet Oh, Younggyu
Lee, Byungjou
Lee, Subum
Kim, Junghwan
Park, Jinhoon
author_sort Oh, Younggyu
collection PubMed
description OBJECTIVE: Although surgical intervention, such as percutaneous vertebroplasty (PVP), is the standard treatment for osteoporotic vertebral compression fractures (OVCFs), its effectiveness and safety are unclear. Therefore, this study compared the safety and efficacy of conservative treatment with that of PVP for acute OVCFs. METHODS: Patients with single-level OVCFs who were treated conservatively with a transdermal fentanyl patch (TFP) or with PVP between March 2013 and December 2017 and followed-up for more than 1 year were retrospectively evaluated. Patients with pathologic fractures, fractures of more than two columns, or a history of PVP were excluded. Clinical outcomes (visual analog scale [VAS] scores) and radiographic factors were evaluated, including changes in the compression rate of the corresponding vertebral body at onset and after 12 months, sagittal Cobb angle at onset and after 6 and 12 months, and the incidence of adjacent compression fractures. RESULTS: Of the 131 patients evaluated, 75 were treated conservatively using TFPs and 56 underwent PVP. We divided the patients into TFP and PVP groups. Their baseline characteristics (including sex, level of fracture, and bone mineral density T-scores) were similar, but the TFP group was significantly younger. The overall VAS score for pain showed a greater decrease during the first month (1 week after PVP) in the PVP group but remained similar in the two groups thereafter. The compression rate after 12 months increased in the TFP group but decreased in the PVP group. Five patients in the PVP group, but none in the TFP group, experienced adjacent compression fractures within 12 months. CONCLUSION: We compared clinical and radiological outcomes between the TFP and PVP groups. The immediate pain reduction effect was superior in the PVP group, but the final clinical outcome was similar. Although the PVP group had a better-preserved compression rate than the TFP group for 1 year, the development of adjacent fractures was significantly higher. Although TFPs seemed to be beneficial in reducing the failure rate of conservative treatment, the possibility of side effects (22.6%, 17 out of 75 patients, in this study) should be carefully monitored.
format Online
Article
Text
id pubmed-6732346
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Neurosurgical Society
record_format MEDLINE/PubMed
spelling pubmed-67323462019-09-12 Percutaneous Vertebroplasty versus Conservative Treatment Using a Transdermal Fentanyl Patch for Osteoporotic Vertebral Compression Fractures Oh, Younggyu Lee, Byungjou Lee, Subum Kim, Junghwan Park, Jinhoon J Korean Neurosurg Soc Clinical Article OBJECTIVE: Although surgical intervention, such as percutaneous vertebroplasty (PVP), is the standard treatment for osteoporotic vertebral compression fractures (OVCFs), its effectiveness and safety are unclear. Therefore, this study compared the safety and efficacy of conservative treatment with that of PVP for acute OVCFs. METHODS: Patients with single-level OVCFs who were treated conservatively with a transdermal fentanyl patch (TFP) or with PVP between March 2013 and December 2017 and followed-up for more than 1 year were retrospectively evaluated. Patients with pathologic fractures, fractures of more than two columns, or a history of PVP were excluded. Clinical outcomes (visual analog scale [VAS] scores) and radiographic factors were evaluated, including changes in the compression rate of the corresponding vertebral body at onset and after 12 months, sagittal Cobb angle at onset and after 6 and 12 months, and the incidence of adjacent compression fractures. RESULTS: Of the 131 patients evaluated, 75 were treated conservatively using TFPs and 56 underwent PVP. We divided the patients into TFP and PVP groups. Their baseline characteristics (including sex, level of fracture, and bone mineral density T-scores) were similar, but the TFP group was significantly younger. The overall VAS score for pain showed a greater decrease during the first month (1 week after PVP) in the PVP group but remained similar in the two groups thereafter. The compression rate after 12 months increased in the TFP group but decreased in the PVP group. Five patients in the PVP group, but none in the TFP group, experienced adjacent compression fractures within 12 months. CONCLUSION: We compared clinical and radiological outcomes between the TFP and PVP groups. The immediate pain reduction effect was superior in the PVP group, but the final clinical outcome was similar. Although the PVP group had a better-preserved compression rate than the TFP group for 1 year, the development of adjacent fractures was significantly higher. Although TFPs seemed to be beneficial in reducing the failure rate of conservative treatment, the possibility of side effects (22.6%, 17 out of 75 patients, in this study) should be carefully monitored. Korean Neurosurgical Society 2019-09 2019-08-30 /pmc/articles/PMC6732346/ /pubmed/31484234 http://dx.doi.org/10.3340/jkns.2019.0086 Text en Copyright © 2019 The Korean Neurosurgical Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Article
Oh, Younggyu
Lee, Byungjou
Lee, Subum
Kim, Junghwan
Park, Jinhoon
Percutaneous Vertebroplasty versus Conservative Treatment Using a Transdermal Fentanyl Patch for Osteoporotic Vertebral Compression Fractures
title Percutaneous Vertebroplasty versus Conservative Treatment Using a Transdermal Fentanyl Patch for Osteoporotic Vertebral Compression Fractures
title_full Percutaneous Vertebroplasty versus Conservative Treatment Using a Transdermal Fentanyl Patch for Osteoporotic Vertebral Compression Fractures
title_fullStr Percutaneous Vertebroplasty versus Conservative Treatment Using a Transdermal Fentanyl Patch for Osteoporotic Vertebral Compression Fractures
title_full_unstemmed Percutaneous Vertebroplasty versus Conservative Treatment Using a Transdermal Fentanyl Patch for Osteoporotic Vertebral Compression Fractures
title_short Percutaneous Vertebroplasty versus Conservative Treatment Using a Transdermal Fentanyl Patch for Osteoporotic Vertebral Compression Fractures
title_sort percutaneous vertebroplasty versus conservative treatment using a transdermal fentanyl patch for osteoporotic vertebral compression fractures
topic Clinical Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732346/
https://www.ncbi.nlm.nih.gov/pubmed/31484234
http://dx.doi.org/10.3340/jkns.2019.0086
work_keys_str_mv AT ohyounggyu percutaneousvertebroplastyversusconservativetreatmentusingatransdermalfentanylpatchforosteoporoticvertebralcompressionfractures
AT leebyungjou percutaneousvertebroplastyversusconservativetreatmentusingatransdermalfentanylpatchforosteoporoticvertebralcompressionfractures
AT leesubum percutaneousvertebroplastyversusconservativetreatmentusingatransdermalfentanylpatchforosteoporoticvertebralcompressionfractures
AT kimjunghwan percutaneousvertebroplastyversusconservativetreatmentusingatransdermalfentanylpatchforosteoporoticvertebralcompressionfractures
AT parkjinhoon percutaneousvertebroplastyversusconservativetreatmentusingatransdermalfentanylpatchforosteoporoticvertebralcompressionfractures